|1.||Ding, Wei-Qun: 9 articles (12/2011 - 04/2005)|
|2.||Bush, Ashley I: 6 articles (09/2015 - 11/2002)|
|3.||Lind, Stuart E: 6 articles (12/2011 - 04/2005)|
|4.||Dou, Q Ping: 6 articles (02/2010 - 01/2005)|
|5.||Volitakis, Irene: 5 articles (09/2015 - 12/2003)|
|6.||Chen, Di: 5 articles (09/2009 - 01/2005)|
|7.||Mao, Xinliang: 4 articles (01/2014 - 11/2008)|
|8.||Yu, Haijun: 4 articles (09/2011 - 01/2009)|
|9.||Tanzi, Rudolph E: 4 articles (07/2008 - 11/2002)|
|10.||Masters, Colin L: 4 articles (07/2008 - 12/2003)|
|1.||Alzheimer Disease (Alzheimer's Disease)
01/01/2006 - "To evaluate the efficacy of clioquinol for the treatment of cognitive impairment due to Alzheimer's disease. "
01/01/2008 - "The Internet was searched using the term: clioquinol, PBT*, MPAC* Randomised double-blind trials in which treatment with clioquinol was administered to participants with Alzheimer's disease in parallel group comparison with placebo are included. "
05/01/2007 - "Successful trials with 5-chloro-7-iodo-8-hydroxyquinoline (clioquinol, CQ) for Alzheimer's disease treatment prompted renewed interest in assessing whether its therapeutic action is related to the coordination of neurotoxic trace metals, such as Cu(II) and Zn(II). "
01/01/2006 - "Randomised double-blind trials in which treatment with clioquinol was administered to participants with Alzheimer's disease in parallel group comparison with placebo are included. "
01/01/2005 - "PBT-1 (clioquinol), is undergoing phase II clinical trials by Prana Biotechnology Ltd for the potential treatment of Alzheimer's disease. "
12/15/2011 - "The present study compared the cytotoxicity of clioquinol with six analogues using human cancer cell lines. "
09/01/2011 - "This study demonstrates for the first time that clioquinol targets post-transcriptional steps of cyclin D1 gene expression in cancer cells, adding new insight into our understanding of its mechanisms of anticancer action."
03/01/2011 - "Given the prior toxicology and pharmacology studies, Clioquinol could be rapidly repositioned for a new anti-cancer indication. "
11/10/2008 - "Such information will aid in the design of clinical trials of oral Clioquinol for new indications such as cancer therapy."
11/13/2014 - "The complexes were also >100-fold more potent than clioquinol in a tumor spheroid model, with values similar to currently used chemotherapeutics for the treatment of solid tumors. "
05/19/1983 - "[Report of experiences with the effect of Linola-Vioform in various dermatoses]."
03/01/1967 - "Treatment of inflammatory dermatoses with a corticosteroid-clioquinol paste."
01/01/1958 - "Bradex-vioform in the treatment of fungus and other skin diseases."
06/21/1957 - "[The use of bradex-vioform in various skin diseases]."
04/24/1953 - "[Bradex and bradex-vioform in therapy of mycotic and bacterial dermatoses]."
12/01/1978 - "A double-blind multicenter study compared the antifungal effectiveness of an iodochlorhydroxyquin-hydrocoritsone cream with that of its individual components in 354 patients with cutaneous fungal infections. "
01/01/2015 - "Despite clinical features mimicking infection or multiple sclerosis, SMON was confirmed as being caused by ingestion of clioquinol, an intestinal antibacterial drug, based on extensive epidemiological studies. "
07/14/2009 - "Effects of clioquinol on memory impairment and the neurochemical modifications induced by scrapie infection in golden hamsters."
01/01/1987 - "Our studies demonstrate the efficacy of prophylactic tetracycline but do not support the use of clioquinol to prevent intestinal infection due to these organisms. "
01/01/1987 - "Comparison of prophylactic tetracycline and clioquinol in a rabbit model of intestinal infection with Vibrio cholerae and Escherichia coli."
01/01/2014 - "We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialized Register, on 29 July 2010 using the terms: Clioquinol OR PBT1 OR PBT2 OR "metal protein" OR MPACS OR MPAC. "
01/01/2012 - "We searched ALOIS, the Cochrane Dementia and Cognitive Improvement Group Specialized Register, on 29 July 2010 using the terms: Clioquinol OR PBT1 OR PBT2 OR "metal protein" OR MPACS OR MPAC. "
01/01/2008 - "The Cochrane Dementia and Cognitive Improvement Group's Specialized Register was searched on 15 February 2007 using the terms clioquinol, PBT*, MPAC*. "
01/01/2006 - "The Cochrane Dementia and Cognitive Improvement Group's Specialized Register was searched on 20 May 2005 using the terms clioquinol and PBT1. "
09/01/2015 - "Clioquinol rescues Parkinsonism and dementia phenotypes of the tau knockout mouse."
|9.||Betamethasone 17-Valerate (Betamethasone 17 Valerate)
|2.||Heterologous Transplantation (Xenotransplantation)